Cell surface Nestin is a biomarker for glioma stem cells

Biochemical and Biophysical Research Communications

Volumn 433, Issue 4, 2013, Pages 496-501

  Jin, Xiong ^a   Jin, Xun ^a   Jung, Ji Eun ^a   Beck, Samuel ^b   Kim, Hyunggee ^a  

^a Korea University   (South Korea)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Secretase; Glioblastoma; Glioma stem cells; Nestin

Indexed keywords

BIOLOGICAL MARKER; CD133 ANTIGEN; CD15 ANTIGEN; NESTIN;

ARTICLE; CANCER STEM CELL; CELL ISOLATION; CELL POPULATION; CELL SELECTION; CELL SURFACE; FLUORESCENCE ACTIVATED CELL SORTING; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD; ANTIGENS, CD15; CELL SHAPE; CELL TRANSFORMATION, NEOPLASTIC; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRODUCIBILITY OF RESULTS; SINGLE-CELL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84876472575     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.021     Document Type: Article

References (47)

1. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507.
2. Nakano I., Kornblum H.I. Brain tumor stem cells. Pediatr. Res. 2006, 59:54R-58R.
3. Johannessen T.C., Bjerkvig R., Tysnes B.B. DNA repair and cancer stem-like cells-potential partners in glioma drug resistance?. Cancer Treat. Rev. 2008, 34:558-567.
4. Chalmers A.J. Radioresistant glioma stem cells-therapeutic obstacle or promising target?. DNA Repair (Amst.) 2007, 6:1391-1394.
5. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
6. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
7. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
8. Son M.J., Woolard K., Nam D.H., Lee J., Fine H.A. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009, 4:440-452.
9. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., Olweus J., Kearney J., Buck D.W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-5012.
10. Corbeil D., Fargeas C.A., Huttner W.B. Rat prominin, like its mouse and human orthologues, is a pentaspan membrane glycoprotein. Biochem. Biophys. Res. Commun. 2001, 285:939-944.
11. Corbeil D., Röper K., Hellwig A., Tavian M., Miraglia S., Watt S.M., Simmons P.J., Peault B., Buck D.W., Huttner W.B. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J. Biol. Chem. 2000, 275:5512-5520.
12. Sanai N., Alvarez-Buylla A., Berger M.S. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 2005, 353:811-822.
13. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
14. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007, 67:4010-4015.
15. Bidlingmaier S., Zhu X., Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J. Mol. Med. (Berl.) 2008, 86:1025-1032.
16. Griguer C.E., Oliva C.R., Gobin E., Marcorelles P., Benos D.J., Lancaster J.R., Gillespie G.Y. CD133 is a marker of bioenergetics stress in human glioma. PLoS One 2008, 3:e3655.
17. Joo K.M., Kim S.Y., Jin X., Song S.Y., Kong D.S., Lee J.I., Jeon J.W., Kim M.H., Kang B.G., Jung Y., Jin J., Hong S.C., Park W.Y., Lee D.S., Kim H., Nam D.H. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab. Invest. 2008, 88:808-815.
18. Wang J., Sakariassen P.Ø., Tsinkalovsky O., Immervoll H., Bøe S.O., Svendsen A., Prestegarden L., Røsland G., Thorsen F., Stuhr L., Molven A., Bjerkvig R., Enger P.Ø. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 2008, 122:761-768.
19. Kerr M.A., Stocks S.C. The role of CD15-(Le(X))-related carbohydrates in neutrophil adhesion. Histochem. J. 1992, 24:811-826.
20. Capela A., Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 2002, 35:865-875.
21. Capela A., Temple S. LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev. Biol. 2006, 291:300-313.
22. Dunphy C.H., Gardner L.J., Evans H.L., Javadi N. CD15(+) acute lymphoblastic leukemia and subsequent monoblastic leukemia: persistence of t(4;11) abnormality and B-cell gene rearrangement. Arch. Pathol. Lab. Med. 2001, 125:1227-1230.
23. Reifenberger G., Sieth P., Niederhaus M., Wechsler W. Expression of CD15 in tumours of the nervous system. Histochem. J. 1992, 24:890-901.
24. Dirks P.B. Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2008, 363:139-152.
25. Strojnik T., Røsland G.V., Sakariassen P.O., Kavalar R., Lah T. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg. Neurol. 2007, 68:133-143.
26. Abdouh M., Facchino S., Chatoo W., Balasingam V., Ferreira J., Bernier G. BMI1 sustains human glioblastoma multiforme stem cell renewal. J. Neurosci. 2009, 29:8884-8896.
27. Suvà M.L., Riggi N., Janiszewska M., Radovanovic I., Provero P., Stehle J.C., Baumer K., Le Bitoux M.A., Marino D., Cironi L., Marquez V.E., Clément V., Stamenkovic I. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 2009, 69:9211-9218.
28. Lendahl U., Zimmerman L.B., McKay R.D. CNS stem cells express a new class of intermediate filament protein. Cell 1990, 60:585-595.
29. Herrmann H., Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr. Opin. Cell Biol. 2000, 12:79-90.
30. Beck S., Jin X., Yin J., Kim S.H., Lee N.K., Oh S.Y., Jin X., Kim M.K., Kim E.B., Son J.S., Kim S.C., Nam D.H., Kim S.H., Kang S.K., Kim H., Choi Y.J. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells. Biomaterials 2011, 32:8518-8528.
31. Soeda A., Park M., Lee D., Mintz A., Androutsellis-Theotokis A., McKay R.D., Engh J., Iwama T., Kunisada T., Kassam A.B., Pollack I.F., Park D.M. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009, 28:3949-3959.
32. Jijiwa M., Demir H., Gupta S., Leung C., Joshi K., Orozco N., Huang T., Yildiz V.O., Shibahara I., de Jesus J.A., Yong W.H., Mischel P.S., Fernandez S., Kornblum H.I., Nakano I. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One 2011, 6:e24217.
33. Miyazaki T., Pan Y., Joshi K., Purohit D., Hu B., Demir H., Mazumder S., Okabe S., Yamori T., Viapiano M., Shin-ya K., Seimiya H., Nakano I. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb. Clin. Cancer Res. 2012, 18:1268-1280.
34. Pollard S.M., Yoshikawa K., Clarke I.D., Danovi D., Stricker S., Russell R., Bayani J., Head R., Lee M., Bernstein M., Squire J.A., Smith A., Dirks P. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009, 4:568-580.
35. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
36. Puente X.S., Sánchez L.M., Overall C.M., López-Otín C. Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 2003, 4:544-558.
37. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., Goate A., Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 1999, 398:518-522.
38. Shih A.H., Holland E.C. Notch signaling enhances nestin expression in gliomas. Neoplasia 2006, 8:1072-1082.
39. Singh S.K., Clarke I.D., Hide T., Dirks P.B. Cancer stem cells in nervous system tumors. Oncogene 2004, 23:7267-7273.
40. Kasper S. Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev. 2008, 4:193-201.
41. Bentivegna A., Conconi D., Panzeri E., Sala E., Bovo G., Viganò P., Brunelli S., Bossi M., Tredici G., Strada G., Dalprà L. Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Cancer Sci. 2010, 101:416-424.
42. Okuno K., Ohta S., Kato H., Taga T., Sugita K., Takeuchi Y. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines. Oncol. Rep. 2010, 23:485-492.
43. Jimeno A., Feldmann G., Suárez-Gauthier A., Rasheed Z., Solomon A., Zou G.M., Rubio-Viqueira B., García-García E., López-Ríos F., Matsui W., Maitra A., Hidalgo M. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol. Cancer Ther. 2009, 8:310-314.
44. Bentahir M., Nyabi O., Verhamme J., Tolia A., Horré K., Wiltfang J., Esselmann H., De Strooper B. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J. Neurochem. 2006, 96:732-742.
45. Michalczyk K., Ziman M. Nestin structure and predicted function in cellular cytoskeletal organization. Histol. Histopathol. 2005, 20:665-671.
46. Park D., Xiang A.P., Zhang L., Mao F.F., Walton N.M., Choi S.S., Lahn B.T. The radial glia antibody RC2 recognizes a protein encoded by Nestin. Biochem. Biophys. Res. Commun. 2009, 382:588-592.
47. Kong L.W., Ding X.Y., Kitani H., Shiurba R., Jing N.H. Evidence for a mouse brain-specific variant of alpha-tubulin. Cell Res. 1999, 9:315-325.